Dynorphin and the kappa 1 ligand [3H]U69,593 binding in the human epileptogenic hippocampus

Epilepsy Research

Volumn 28, Issue 3, 1997, Pages 189-205

  De Lanerolle, N C ^a   Williamson, A ^a   Meredith, C ^a   Kim, J H ^a   Tabuteau, H ^a   Spencer, D D ^a   Brines, M L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dynorphin; Hippocampus; Opiate Receptors; Plasticity; Temporal Lobe Epilepsy

Indexed keywords

DYNORPHIN; KAPPA OPIATE RECEPTOR;

ARTICLE; BINDING SITE; CELL LOSS; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; EPILEPSY; EPILEPTOGENESIS; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIGAND BINDING; NERVE EXCITABILITY; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; BENZENEACETAMIDES; BINDING SITES; CELL COUNT; DYNORPHINS; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NALOXONE; NEURONS; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; TRITIUM;

EID: 0030828419     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(97)00044-2     Document Type: Article

References (40)

1. Weber E, Evans CJ, Barchas JD. Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions. Nature 1982;299:77-9.
2. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 1989;495:387-95.
3. Houser CR, Miyashiro JE, Swartz BE, Walsh GO, Rich JR, Delgado-Escueta AV. Altered patterns, of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J Neurosci 1990;10:267-82.
4. Hong JS, McGinty JF, Lee PHK, Xie CW, Mitchell CL. Relationship between hippocampal opoid peptides and seizures. Prog Neurobiol 1993;40:507-28.
5. Iadarola MJ, Shin C, McNamara JO, Yang H-YT. Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling. Brain Res 1986;365:185-91.
6. McGinty JF, Kanamatsu T, Obie J, Dyer RS, Mitchell CL, Hong J-S. Amygdaloid kindling increases enkephalin-like immunoreactivity but decreases dynorphin-A-like immunoreactivity in rat hippocampus. Neurosci Lett 1986;71:31-6.
7. Xie CW, Lee PHK, Takeuchi K, Owayang V, Li SJ, Douglass J, Hong JS. Single or repeated electroconvulsive shocks alter the levels of prodynorphin and proenkephalin mRNAs in rat brain. Mol Brain Res 1989;6:11-9.
8. Berman E, Adler MW. The anticonvulsant effects of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacol 1984;23:367-71.
9. ij, rats. Neurosci Lett 1995;186:131-4.
10. Morris BJ, Johnston HM. A role for hippocampal opioids in long-term functional plasticity. Trends Neurosci 1995;18:350-5.
11. 1-9 are ligands for the κ-subtype of opiate receptor. Nature 1982;299:79-81.
12. Walker JM, Moises HC, Coy DH, Baldrighi G, Akil H. Nonopiate effects of dynorphin and des-tyr-dynorphin. Science 1982;218:1136-8.
13. Morris BJ, Moneta ME, ten Bruggencate G, Höllt V. Levels of prodynorphin mRNA in rat dentate gyrus are decreased during hippocampal kindling. Neurosci Lett 1987;80:298-302.
14. Naranjo JR, Iadorola MJ, Costa E. Changes in the gymanic state of brain pro-enkephalin derived peptide during amygdaloid kindling. J Neurosci Res 1986;16:75-87.
15. Babb TL, Pretorius JK, Kupfer WR, Mathern GW, Crandall PH, Levesque MF. Aberrant synaptic reorganization in human epileptic hippocampus: evidence for feedforward excitation. Dendron 1992;1:7-25.
16. Rees H, Ang L-C, Shul DD, George DH, Begley H, McConnell T. Increase in enkephalin-like immunoreactivity in hippocampi of adults with generalized epilepsy. Brain Res 1994;652:113-9.
17. de Lanerolle NC, Kim JH, Brines ML. Cellular and molecular alterations in partial epilepsy. Clin Neurosci 1994;2:64-81.
18. Spencer DD, Spencer SS. Surgery for epilepsy. Neurol Clin 1985;3:313-30.
19. Spencer DD, Spencer SS, Mattson RH, Williamson PD, Novelly R. Access to posterior medial temporal lobe structures in the surgical treatment of temporal lobe epilepsy. Neurosurg 1984;15:667-71.
20. de Lanerolle NC, Brines ML, Kim JH, Williamson A, Philips MF, Spencer DD, Neurochemical remodelling of the hippocampus in human temporal lobe epilepsy. In: Engel JJ, Wasterlain C, Cavalheiro EA, Heinemann U, Avanzini G, editors. Molecular Neurobiology of Epilepsy. Amsterdam: Elsevier, 1992:205-220.
21. Spencer DD. Classifying the epilepsies by substrate. Clin Neurosci 1994;2:104-9.
22. Hsu S, Raine L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577.
23. Wagner JJ, Caudle RM, Chavkin C. κ-opioid decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J Neurosci 1992;12:132-41.
24. Kim JH, Guimaraes PO, Shen M-Y, Masukawa LM, Spencer DD. Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas. Acta Neuropathol 1990;80:41-5.
25. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94:239-47.
26. Williamson A, Spencer SS, Spencer DD. Depth electrode studies and intracellular dentate granule cell recordings in temporal lobe epilepsy. Ann Neurol 1995;38:778-86.
27. de Lanerolle NC, Brines ML, Williamson A, Kim JH, Spencer DD. Neurotransmitters and their receptors in human temporal lobe epilepsy. In: Ribak CE, Gall CM, Mody I, editors. The Dentate Gyrus and Its Role in Seizures. Amsterdam: Elsevier, 1992:235-250.
28. Williamson A, Shepherd GM, Spencer DD. Comparison of human and rodent dentate granule cells maintained in vitro. Brain Res 1993;622:194-202.
29. Sutula T, Cascino G, Cavazos J, Pavada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-30.
30. Zhang N, Houser CR. Dynorphin immunoreactivity in the dentate gyrus in human temporal lobe epilepsy: an electron microscopic study of reorganized mossy fiber synapses. Soc Neurosci Abstr 1995;21:1962.
31. de Lanerolle NC, Magge SN, Phillips MF, Trombley P, Spencer DD, Brines M. Adaptive changes of epileptic human temporal lobe tissue: properties of neurons and glia. In: Wolf P, editor. Seizures and Syndromes in Epilepsy. London: J. Libbey, 1994:431-448.
32. Dudek FE, Obenaus A, Schweitzer JS, Wuarin JP. Functional significance of hippocampal plasticity in epileptic brain: electrophysiological changes of the dentate granule cells associated with mossy fiber sprouting. Hippocampus 1994;4:259-65.
33. Weihe E, Millan MJ, Höllt V, Nohr D, Herz A. Induction of the gene encoding pro-dynorphin by experimentally induced arthritis enhances staining for dynorphin in the spinal cord of rats. Neurosci 1989;31:77-95.
34. Sperk G, Marksteiner J, Gruber B, Bellmann R, Mahata M, Ortler M. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neurosci 1992;50:831-46.
35. Zhu Z-Z, Armstrong DL, Grossman RG, Hamilton WJ. Tyrosine hydroxylase-immunoreactive neurons in the temporal lobe in complex partial seizures. Ann Neurol 1990;27:564-72.
36. Hökfelt T, Zhang X, Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 1994;17:22-30.
37. Faden AI. Opiod and nonopioid mechanisms may contribute to dynorphin's pathological actions in spinal cord injury. Ann Neurol 1990;27:67-74.
38. Drake CT, Terman GW, Simmons ML, Milner TA, Kunkel DD, Schwartzkroin PA, Chavkin C. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J Neurosci 1994;14:3736-50.
39. Simmons ML, Terman GW, Drake CT, Chavkin C. Inhibition of glutamate release by presynaptic κ1-opioid receptors in the guinea pig dentate gyrus. J Neurophysiol 1994;72:1697-705.
40. Herkenham, M, McLean, S. Mismatches between receptor and transmitter localizations in the brain. In: Boast CA, Snowhill EW, Altar CA, editors. Quantitative Receptor Autoradiography. New York: Alan R. Liss, 1986:137-172.